Medical history of chemotherapy or immunosuppressive drug treatment and risk of amyotrophic lateral sclerosis (ALS)

Overview of attention for article published in Journal of Neurology, July 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript

Cited by Centers for Disease Control and Prevention (CDC) on 01 Dec 2017

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.